Meplazumab Completed Phase 3 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 3 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT05679479 | Study on the Safety and Efficacy of Meplazumab for Injection in Severe Patients With COVID-19 |